(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

SAL DE 4-AMINO-N-[4-(METOXIMETIL)FENIL]-7-(1-METILCICLOPROPIL)-6-(3-MORFOLINOPROP-1-IN-1-IL)-7H-PIRROLO[2,3?D]PIRIMIDINA-5-CARBOXAMIDA E COMPOSIÇÃO FARMACÊUTICA

Em AnáliseInvention PatentPCT · EP2021082093

Application data

Number

112023007801

Type

Invention Patent

Filing

11/18/2021

Publication

06/13/2023

PCT

EP2021082093

Progress at the INPI

  1. Filing11/18/21
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 11/18/2021. It awaits formal examination and publication in the RPI gazette.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 06/10/2025. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

HELSINN HEALTHCARE SA

CH

TAIHO PHARMACEUTICAL CO., LTD.

JP

See this company's full portfolio

Inventors

C. I. (pessoa física)

IT

E. M. (pessoa física)

IT

G. F. (pessoa física)

CH

S. G. (pessoa física)

IT

T. F. (pessoa física)

IT

Technical data

Priority claims

US

63/116,191 · 11/20/2020

Abstract

SAL DE 4-AMINO-N-[4-(METOXIMETIL)FENIL]-7-(1-METILCICLOPROPIL)-6-(3-MORFOLINOPROP-1-IN-1-IL)-7H-PIRROLO[2,3D]PIRIMIDINA-5-CARBOXAMIDA E COMPOSIÇÃO FARMACÊUTICA. São fornecidas várias formas cristalinas de 4-amino-N-[4-(metoximetil)fenil]-7-(1-metilciclopropil)-6-(3-morfolinoprop-1-in-1-il)-7H-pirrolo[2,3?d]pirimidina-5-carboxamida, métodos de produção das mesmas e métodos de uso das mesmas para inibição de RET.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Transferência deferida

#25.1

06/10/2025

RPI 2840

Notificação de entrada na fase nacional - PCT

#1.3

06/13/2023

RPI 2736

Alteração de dados cadastrais

#1.1

05/02/2023

RPI 2730

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.